Symbol | Company | Weighting |
---|---|---|
EYPT | EYEPOINT PHARMACEUTICALS | 2.44% |
INSM | INSMED INC | 2.42% |
AKRO | AKERO THERAPEUTICS INC | 2.34% |
PSNL | PERSONALIS | 2.21% |
BPMC | BLUEPRINT MEDICINES CORPORATION | 2.06% |
SPRY | ARS PHARMACEUTICALS | 1.96% |
ADPT | ADAPTIVE BIOTECHNOLOGIES CORPORATION | 1.94% |
LENZ | LENZ THERAPEUTICS | 1.88% |
IMVT | IMMUNOVANT INC | 1.84% |
GKOS | GLAUKOS CORPORATION | 1.80% |
ASND | ASCENDIS PHARMA A/S DKK 1.0 ADR | 1.80% |
ICLR | ICON PLC | 1.76% |
CYTK | CYTOKINETICS INC | 1.75% |
PCVX | VAXCYTE INC | 1.75% |
RARE | ULTRAGENYX PHARMACEUTICAL INC | 1.74% |
AZN | ASTRAZENECA PLC-ADR | 1.72% |
DHR | DANAHER CORP | 1.71% |
DNLI | DENALI THERAPEUTICS INC. | 1.71% |
HALO | HALOZYME THERAPEUTICS INC | 1.71% |
UNH | UNITEDHEALTH GROUP INC | 1.71% |
ABVX | ABIVAX SA | 1.69% |
TEVA | TEVA PHARMACEUTICAL INDS LTD | 1.68% |
RVMD | REVOLUTION MEDICINES INC | 1.68% |
RMD | RESMED INC | 1.68% |
MCK | MCKESSON CORP | 1.67% |
THC | TENET HEALTHCARE CORP | 1.67% |
MDT | MEDTRONIC PLC | 1.66% |
EWTX | EDGEWISE THERAPEUTICS | 1.64% |
CRNX | CRINETICS PHARMACEUTICALS INC | 1.63% |
ABBV | ABBVIE INC | 1.63% |
HUM | HUMANA INC | 1.63% |
GEHC | GE HEALTHCARE TECHNOLOGIES INC | 1.62% |
VCEL | VERICEL CORP | 1.62% |
ABT | ABBOTT LABORATORIES | 1.62% |
CDXS | CODEXIS INC | 1.60% |
ALC | ALCON INC | 1.59% |
HCA | HCA HOLDINGS INC | 1.59% |
ELV | ELEVANCE HEALTH INC | 1.58% |
BDX | BECTON DICKINSON & CO | 1.58% |
TARS | TARSUS PHARMACEUTICALS | 1.57% |
SYK | STRYKER CORP | 1.57% |
BSX | BOSTON SCIENTIFIC | 1.57% |
DXCM | DEXCOM INC | 1.57% |
BMRN | BIOMARIN PHARAMCEUTICAL INC | 1.57% |
RGEN | REPLIGEN CORP | 1.55% |
GMED | GLOBUS MEDICAL INC CLASS A | 1.55% |
ADMA | ADMA BIOLOGICS, INC. | 1.55% |
ARGX | ARGENX SE ADR | 1.54% |
ZTS | ZOETIS INC | 1.54% |
SNY | SANOFI- AVENTIS- ADR | 1.53% |
DYN | DYNE THERAPEUTICS, INC. | 1.53% |
TNDM | TANDEM DIABETES CARE INC | 1.48% |
ISRG | INTUITIVE SURGICAL INC | 1.46% |
TVTX | TRAVERE THERAPEUTICS INC | 1.44% |
SMMT | SUMMIT THERAPEUTICS INC. | 1.41% |
KRRO | KORRO BIO | 1.38% |
INSP | INSPIRE MEDICAL SYSTEMS, INC. | 1.37% |
TMO | THERMO FISHER SCIENTIFIC INC | 1.35% |
REGN | REGENERON PHARMACEUTICALS | 1.18% |
SRPT | SAREPTA THERAPEUTICS INC | 0.95% |
Read a prospectus and summary prospectus (if available) carefully before investing. It contains the investment objective, risks charges, expenses and the other information, which should be considered carefully before investing. To obtain a prospectus and summary prospectus (if available) click here or call 800.820.0888.
Investing involves risk, including the possible loss of principal.
Guggenheim Investments represents the following affiliated investment management businesses of Guggenheim Partners, LLC: Guggenheim Partners Investment Management, LLC, Security Investors, LLC, Guggenheim Funds Distributors, LLC, Guggenheim Funds Investment Advisors, LLC, Guggenheim Corporate Funding, LLC, Guggenheim Wealth Solutions, LLC, Guggenheim Partners Europe Limited, Guggenheim Partners Japan Limited, GS GAMMA Advisors, LLC, and Guggenheim Private Investments, LLC. Securities offered through Guggenheim Funds Distributors, LLC.
© 2025 Guggenheim Investments. All Rights Reserved.
Research our firm with FINRA Broker Check.
• Not FDIC Insured • No Bank Guarantee • May Lose Value
This website is directed to and intended for use by citizens or residents of the United States of America only. The material provided on this website is not intended as a recommendation or as investment advice of any kind, including in connection with rollovers, transfers, and distributions. Such material is not provided in a fiduciary capacity, may not be relied upon for or in connection with the making of investment decisions, and does not constitute a solicitation of an offer to buy or sell securities. All content has been provided for informational or educational purposes only and is not intended to be and should not be construed as legal or tax advice and/or a legal opinion. Always consult a financial, tax and/or legal professional regarding your specific situation. Investing involves risk, including the possible loss of principal.